Author

Marina Alcaide-Miranda

Hospital del Mar Research Institute Barcelona (HMRIB);ORCID 0009-0001-1346-7246Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alba VidaliD· 1 shared Anna BigasiD· 1 shared Arnau IglesiasiD· 1 shared Cinzia BenettiiD· 1 shared Eleonora PonzoiD· 1 shared Francesco BoccalatteiD· 1 shared Giulia FaccincaniiD· 1 shared Jessica GonzaleziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alba VidalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 3, 2026

SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS

Violeta Garcia-Hernandez, Maria Maqueda, Giulia Faccincani…·Anna Bigas

This study shows SMARCA4 mutations in T-ALL lead to chemotherapy resistance by altering chromatin remodeling at AP-1 regulatory regions, reducing stress response genes.

DOI 10.64898/2026.11.01.763277

humanATAC-seq

𝕏 PostBluesky